Baseline Chloride Levels are Associated with the Incidence of Contrast-Associated Acute Kidney Injury by 媛뺤떊�슧 et al.
1SCIEnTIfIC REpORts | 7: 17431  | DOI:10.1038/s41598-017-17763-7
www.nature.com/scientificreports
Baseline Chloride Levels are 
Associated with the Incidence of 
Contrast-Associated Acute Kidney 
Injury
Hyung Jung Oh1,2, Sungwon Kim3, Jung Tak Park4, Sang-Joon Kim5, Seung Hyeok Han  4, 
Tae-Hyun Yoo4, Dong-Ryeol Ryu  1,6,7, Shin-Wook Kang4,8 & Yong Eun Chung  3,8
Although hypo- and hyperchloremia have been associated with worsening renal outcomes, there has 
been no study that correlates hypo- and hyperchloremia and the incidence of contrast-associated acute 
kidney injury (CA-AKI). A total of 13,088 patients with less than 2.0 mg/dL of serum creatinine (Cr) who 
underwent contrast-enhanced abdominal CT (CECT) were included. Patients were divided into 3 groups 
based on Cl (the hypo-, normo- and hyperchloremia groups). Patients were also classified by baseline Cr 
(<1.2; the ‘Normal Cr group’ and 1.2–2.0 mg/dL; the ‘Slightly increased Cr group’). Multivariate logistic 
regression analysis was used to reveal the association between Cl and CA-AKI. Among patients, 2,525 
(19.3%) and 241 (1.8%) patients were classified in the hypo- and hyperchloremia group. The incidence 
of CA-AKI was significantly lower in the normochloremia group (4.0%) compared to the hypo- (5.4%) 
and hyperchloremia groups (9.5%). On multivariate logistic regression, hypochloremia was significantly 
associated with the incidence of CA-AKI compared with normochloremia (1.382, P = 0.002). Moreover, 
hypochloremia was still significantly associated with the incidence of CA-AKI in ‘Normal Cr group’ 
compared with normochloremia (1.314, P = 0.015), while hyperchloremia did not show significant 
association with CA-AKI incidence. In conclusion, hypochloremia might be associated with the incidence 
of CA-AKI even in patients who have normal-range Cr levels.
Acute deterioration of renal function due to iodinated contrast agents, defined as contrast-associated acute kid-
ney injury (CA-AKI), is generally mild and transient, but sometimes can result in lasting renal dysfunction and 
need for renal replacement therapy1–3. CA-AKI is the leading cause of new onset renal failure in hospitalized 
patients, with the highest risk being observed in patients with pre-existing impaired renal function1–3, and it 
is significantly associated with increases in in-hospital and long-term morbidity and mortality, acceleration of 
chronic renal disease, and increased costs for medical care4.
Although the pathophysiology of CA-AKI is poorly understood, it may include acute vasoconstriction result-
ing in renal hypoperfusion, hypoxia-induced oxidative stress, and free radicals generated within the acid envi-
ronment of the renal medulla5. However, since there is no specific therapy for CA-AKI and because the disease 
is mostly iatrogenic, prevention is considered to be of paramount importance, and a variety of approaches have 
been suggested to prevent CA-AKI by targeting these pathomechanisms6–11; 24-hour volume supplementation 
with sodium chloride 0.9% is one approach still accepted and it is considered a cornerstone in the prevention of 
CA-AKI in clinical practice12,13. However, sodium chloride saline is chloride-rich14–16, and supplementing patients 
with the solution can lead to hyperchloremia after fluid replacement16,17. Also, the consequent hyperchloremic 
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metabolic acidosis derived from chloride-rich solutions has been associated with poorly progressive outcomes in 
critically ill patients16,18–20.
Hypochloremia has also been independently associated with increased risk of mortality in critically ill 
patients, and this has been explained with the occurrence of metabolic alkalosis21. However, there are only a 
few observational studies evaluating the association of hypochloremia with hospital morbidity22,23. Moreover, 
no studies have been done on the correlation between hypochloremia and the incidence of CA-AKI. Thus, the 
aim of this study was primarily to investigate the association between the incidence of CA-AKI and baseline 
serum chloride concentrations by stratifying patients into three groups (hypochloremia, normochloremia, and 
hyperchloremia). Secondarily, we evaluated how changes in chloride levels from the baseline level affected the 
incidence of CA-AKI for each group.
Results
Baseline characteristics. The mean age was 59.0 ± 15.3 years, and 7,635 (58.3%) patients were male. In 
addition, the mean body mass index (BMI) was 22.7 ± 3.5 kg/m2, and the detailed demographics are summarized 
in Table 1.
When these patients were divided into three groups (hypochloremia, normochloremia, and hyperchloremia), 
2,525 (19.3%) patients were in the hypochloremia group, and 241 (1.8%) patients were in the hyperchloremia 
group. Most of the patients were inpatients [11539 (88.1%)], and the hyperchloremia group had the highest por-
tion of inpatients (94.7%) among the three groups with statistical significance. Patients in the hyperchloremia 
group were significantly older, and had more diabetes mellitus (DM), hypertension, and coronary artery dis-
ease (CAD) compared to the other groups, and there were significantly more males in the hypochloremia group 
compared to the other groups. In the normochloremia group, the BMI was significantly higher than the other 
groups. The administered volume of contrast media was also significantly different between the groups. However, 
the volume per weight was the same for all groups because the contrast media volume was adjusted to each 
patient’s body weight (2 mL/kg). Moreover, of the laboratory data, serum blood urea nitrogen (BUN), creatinine 
(Cr), sodium, and chloride concentrations were significantly increased in the hyperchloremia group, whereas 
the serum total CO2 level was significantly elevated in the hypochloremia group compared to the other groups 
(Table 1). In addition, CA-AKI incidence was the highest in the hyperchloremia group (9.5%), and the second 
highest in the hypochloremia group (5.4%), with statistically significance compared to the normochloremia 
group (4.0%). Moreover, there was also significant difference in the incident rate of CA-AKI between hypochlo-
remia and hyperchloremia groups (Table 1 and Fig. 1).
Hypochloremia is associated with incidence of CA-AKI. Univariate analysis showed that both 
hypochloremia (RR; 1.394, 95% CI; 1.143–1.700, P = 0.001) and hyperchloremia (2.561, 95% CI; 1.650–3.984, 
P < 0.001) were significantly related to increased CA-AKI incidence compared to normochloremia. In addition, 
hypochloremia was significantly associated with CA-AKI incidence compared to normochloremia even after 
Variables
Total  
(n = 13,088, 100%)
Hypochloremia 
(n = 2,525, 19.3%)
Normochloremia 
(n = 10,322, 78.9%)
Hyperchloremia 
(n = 241, 1.8%) p-value
Age, years 59.0 ± 15.3 60.0 ± 14.8 58.7 ± 15.4 64.2 ± 15.9 <0.001
Male, n (%) 7,635 (58.3%) 1,504 (59.6%) 6,011 (58.2%) 120 (49.8%) 0.012
BMI, kg/m2 22.7 ± 3.5 22.2 ± 3.6 22.9 ± 3.4 22.8 ± 4.1 <0.001
Inpatients, n (%) 11539 (88.2%) 2391 (94.7%) 8913 (86.3%) 235 (97.5%) <0.001
Comorbid disease, n(%)
 DM 3,800 (29.0%) 873 (34.6%) 2,841 (27.5%) 86 (35.7%) <0.001
 Hypertension 5,881 (44.9%) 1,182 (46.8%) 4,559 (44.2%) 140 (58.1%) <0.001
 Dyslipidemia 2,361 (18.0%) 452 (17.9%) 1,855 (18.0%) 54 (22.4%) 0.205
 CAD 1,368 (10.5%) 266 (10.5%) 1,055 (10.2%) 47 (19.5%) <0.001
 Heart failure 506 (3.9%) 104 (4.1%) 386 (3.7%) 16 (6.6%) 0.053
Contrast volume, mL 120.5 ± 20.0 117.3 ± 20.9 121.4 ± 19.6 118.1 ± 22.3 <0.001
Laboratory data
 BUN, mg/dL 16.1 ± 8.6 17.1 ± 9.6 15.6 ± 8.1 23.4 ± 13.7 <0.001
 Creatinine, mg/dL 0.76 ± 0.26 0.74 ± 0.27 0.76 ± 0.26 0.84 ± 0.32 <0.001
 Sodium, mEq/L 137.5 ± 4.5 132.0 ± 4.5 138.7 ± 3.1 145.1 ± 5.1 <0.001
 Chloride, mEq/L 101.1 ± 4.9 93.9 ± 3.5 102.5 ± 2.9 113.6 ± 3.8 <0.001
 tCO2, mEq/L 23.8 ± 3.6 24.4 ± 4.1 23.7 ± 3.3 20.5 ± 4.3 <0.001
CA-AKI rate, n (%) 568 (4.3%) 137 (5.4%) 408 (4.0%) 23 (9.5%) <0.001
Table 1. Baseline characteristics among the patients performing contrast CT, but with less than 2.0 mg/dL of 
serum creatinine at baseline. Data are expressed as mean (with standard deviation) or n (%); Abbreviations; 
DM, diabetes mellitus; CAD, coronary arterial disease; BUN, blood urea nitrogen; tCO2, total CO2; CA-
AKI, contrast-associated acute kidney injury. Hypochloremia; chloride level less than 98 mEq/L at baseline; 
Normochloremia; chloride level between 98 to 110 mEq/L at baseline; Hyperchloremia; chloride level over 110 
mEq/L at baseline.
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adjusting for several covariables [relative risk (RR), 1.382; 95% confidence interval (CI), 1.128–1.693; P = 0.002], 
whereas hyperchloremia was marginally related to the CA-AKI incidence compared to normochloremia (RR, 
1.566; 95% CI, 0.929–2.481; P = 0.056) (Table 2 and Fig. 2).
The incidence of CA-AKI according to creatinine levels. The same analyses were conducted in patients 
who had serum Cr concentrations of less than 1.2 mg/dL (the ‘Normal Cr group’, n = 12,280) or 1.2 to 2.0 mg/
dL (the ‘Slightly increased Cr group’, n = 808) serum Cr concentrations at baseline, respectively, and the baseline 
characteristics are described in Supplementary Tables 1 and 2.
Multivariate logistic analyses presented that hypochloremia was still significantly associated with CA-AKI 
incidence in the ‘Normal Cr group’ compared with normochloremia (RR, 1.314; 95% CI, 1.550–1.636; P = 0.015), 
while hyperchloremia did not show significant association with the CA-AKI incidence in ‘Normal Cr group’. In 
‘Slightly increased Cr group’, neither hypochloremia nor hyperchloremia was significantly related to CA-AKI 
incidence (Table 3).
Effect of increases in chloride concentration on the incident rate of CA-AKI. We examined the 
post chloride concentration when the post Cr was measured and calculated delta chloride (ΔCl). Positive ΔCl, 
defined by an increase in chloride concentration from the baseline concentration, was significantly associated 
with a reduction in CA-AKI incidence in all groups of hypochloremia (in both the ‘Normal Cr group’ and the 
‘Slightly increased Cr group’) compared to negative ΔCl (in the ‘Normal Cr group’, RR, 0.318; 95% CI, 0.193–
0.527; P < 0.001, in the ‘Slightly increased Cr group’, RR, 0.053; 95% CI, 0.009–0.326; P = 0.002), while in hyper-
chloremia group, positive ΔCl was significantly related to an increase in CA-AKI incidence in the ‘Normal Cr 
group’ compared to negative ΔCl (RR, 3.092; 95% CI, 1.080–10.655; P = 0.036) (Table 4).
Figure 1. The rate of CA-AKI incidence. CA-AKI incidence was the highest in the hyperchloremia group 
(9.5%), and the second highest in the hypochloremia group (5.4%), with statistically significance compared to 
the normochloremia group (4.0%). Moreover, there was also significant difference in the incident rate of CA-
AKI between the hypochloremia and hyperchloremia groups Abbreviations; CA-AKI, contrast-associated acute 
kidney injury.
Variables
Univariate Multivariate
RR (95% CI) P-value RR (95% CI) P-value
Normochloremia Reference Reference
Hypochloremia 1.394 (1.143–1.700) 0.001 1.382 (1.128–1.693) 0.002
Hyperchloremia 2.564 (1.650–3.984) <0.001 1.566 (0.989–2.481) 0.056
Table 2. Univariate and multivariate logistic regression analysis for the incidence of CA-AKI on the baseline 
chloride level (n = 13,088). Abbreviations; RR, relative risk; CI, confidence interval; CA-AKI, contrast-
associated acute kidney injury. Adjusted for age, sex, admission status, comorbidity diseases including DM, 
hypertension, coronary artery disease, and heart failure, serum creatinine level, serum BUN level, serum tCO2. 
Hypochloremia; chloride level less than 98 mEq/L at baseline. Normochloremia; chloride level between 98 to 
110 mEq/L at baseline. Hyperchloremia; chloride level over 110 mEq/L at baseline.
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Discussion
Several previous studies described a positive correlation between chloride levels and severity of AKI19,20,24. 
Especially, Yunos et al.24 demonstrated that chloride-restrictive solution results in a lower incidence of AKI com-
pared with chloride-liberal fluid strategies in critically ill patients. However, recent studies could not prove that 
sodium bicarbonate was superior to isotonic sodium chloride for preventing incidence of CA-AKI25,26. Therefore, 
we tried to identify the association between CA-AKI incidence and baseline serum chloride concentrations and 
to evaluate what effect an increase in chloride level would have on the incidence of CA-AKI. In the current study, 
the rate of CA-AKI incidence was significantly increased in the hypochloremia group by 38.2% compared to the 
normochloremia group, and was marginally increased in the hyperchloremia group compared to the normochlo-
remia group. In contrast, hypochloremia was significantly associated with an increase in CA-AKI incidence only 
in the ‘Normal Cr group’, while there were no significant associations between incidence of CA-AKI incidence 
and hyperchloremia in the ‘Normal Cr group’. Plus, neither hypochloremia nor hyperchloremia was significantly 
related to CA-AKI incidence in the ‘Slightly increased Cr group’. However, positive ΔCl was significantly associ-
ated with reduced CA-AKI incidence in the hypochloremia group compared with negative ΔCl, whereas it was 
significantly related to increased CA-AKI incidence in the hyperchloremia group of the ‘Normal Cr group’.
Hypochloremia is related to mortality in critically ill patients, and this is thought to be due to metabolic alkalosis27,28, 
but the main factor responsible for mortality due to hypochloremia and metabolic alkalosis is unclear23,29. Tani et al.23 
showed that hypochloremic patients with metabolic acidosis had a higher mortality rate compared with those 
with metabolic alkalosis, suggesting that hypochloremia is associated with mortality independently of metabolic 
alkalosis. Moreover, hypochloremia could be a sign of illness severity as a result of dysregulated homeostasis22, 
and it can be related to increased CA-AKI incidence compared with normochloremia. In this study, patients 
with hypochloremia were also significantly older, and had more DM and hypertensive comorbidity diseases 
than patients with normochloremia. However, hypochloremia was still independently associated with increased 
Figure 2. Adjusted relative risk of CA-AKI. Hypochloremia was significantly associated with CA-AKI 
incidence compared to normochloremia even after adjusting for several covariables, whereas hyperchloremia 
was marginally related to CA-AKI incidence compared to normochloremia. Abbreviations; CA-AKI, contrast-
associated acute kidney injury.
Variables
Univariate Multivariate
RR (95% CI) P-value RR (95% CI) P-value
Normal Cr group (n = 12,280)
 Normochloremia Reference Reference
 Hypochloremia 1.347 (1.086–1.671) 0.007 1.314 (1.550–1.636) 0.015
 Hyperchloremia 2.356 (1.419–3.913) 0.001 1.360 (0.799–2.315) 0.257
Slightly increased Cr group (n = 808)
 Normochloremia Reference Reference
 Hypochloremia 1.781 (1.048–3.027) 0.033 1.641 (0.940–2.866) 0.082
 Hyperchloremia 2.303 (0.912–5.819) 0.078 2.322 (0.872–6.186) 0.092
Table 3. Subgroup analysis for the incidence of CA-AKI on the baseline chloride level depending on serum 
creatinine level [‘Normal Cr group’ (n = 12,280) and ‘Slightly increased Cr group (n = 808)]. Abbreviations; 
CA-AKI, contrast-associated acute kidney injury; RR, relative risk; CI, confidence interval; Cr, creatinine. 
Adjusted for age, sex, admission status, comorbidity diseases including DM, hypertension, coronary artery 
disease, and heart failure, serum creatinine level, serum BUN level, serum tCO2. Normal Cr group; patients 
who had a serum Cr level of less than 1.2 mg/dL. Slightly increased Cr group; patients who had 1.2 ≤ serum Cr 
levels < 2.0 mg/dL. Hypochloremia; chloride level less than 98 mEq/L at baseline. Normochloremia; chloride 
level between 98 to 110 mEq/L at baseline. Hyperchloremia; chloride level over 110 mEq/L at baseline.
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CA-AKI incidence even after adjusting for the above factors, suggesting that hypochloremia was associated with 
an increase in CA-AKI incidence, independent of the disease comorbidity. Unfortunately, we could not measure 
serial total CO2 levels in these patients to evaluate changes in acid-base. This is thought to be one of several limi-
tations that can explain why positive ΔCl helped to reduce the incidence of CA-AKI in the hypochloremia group, 
but aggravated the incident rate of CA-AKI in hyperchloremia group compared with negative ΔCl. However, 
based on our results, active correction of serum chloride levels before contrast-enhanced CT examination might 
help prevent CA-AKI incidence in hypochloremic milieu.
In comparison, hyperchloremia was not related to the incidence of CA-AKI in this study. Unlike previous 
studies, the hyperchloremia group was comprised of only 248 (1.8%) patients, hampering identification of signif-
icant associations between hyperchloremia and the increased CA-AKI incident rate. Thus, further studies involv-
ing larger populations are warranted to determine the relationship between hyperchloremia and CA-AKI. In 
contrast, since positive ΔCl was significantly related to an increase of CA-AKI incidence compared with negative 
ΔCl in the hyperchloremia group of the ‘Normal Cr group’, caution should be taken not to elevate chloride levels 
when patients are in a hyperchloremic condition, even though they might need contrast CT examinations.
Although alkalization with bicarbonate perfusion may attenuate the production of hydroxyl radicals and thus 
reduce the formation of reactive oxygen species30, bicarbonate solution cannot be determined as superior to saline 
solution for preventing CA-AKI incidence25,26. However, this study can suggest that additional interventional 
studies to investigate the superiority of each solution (bicarbonate solution vs. saline solution) may be useful after 
patients are stratified according to baseline chloride levels.
As seen in Supplementary Table 3, the ‘No CA-AKI group’ used a significantly higher total contrast volume 
compared to the ‘CA-AKI group’ in the ‘Slightly increased Cr group’, while there were no significant differences 
in the total contrast volume used between the two groups in all the enrolled patients and the ‘Normal Cr group’. 
However, since the amount of contrast agent injected is adjusted to each patient’s body weight (2 ml/kg), the 
administered contrast volume per body weight (kg) was the same throughout this study. The difference in total 
contrast volume between the three groups of patients with Cr of 1.2 to 2.0 mg/dL might originate from different 
body weights.
There are several limitations in this study. First, this was retrospective cohort study and thus was subject to 
selection bias. Second, patients were arbitrarily classified into three groups according to our hospital reference 
values, and consequently, patients were distributed unevenly among the three groups. However, there are no 
established cut-off values for hypo-, normo-, or hyperchloremia19,22,23; most studies use cut-off values of 98 mEq/L 
for hypochloremia and 110 mEq/L for hyperchloremia19,22. Third, only patients with a serum Cr concentration 
of less than 2.0 mg/dL were selected arbitrarily. Thus, our findings cannot be extrapolated beyond 2.0 mg/dL of 
serum Cr. Fourth, the current status of patients and the reasons for CT examination were not investigated. Fifth, 
we did not investigate how acid‒base changed according to alterations of the chloride level, and it was hard to 
explain the pure effect of chloride level changes on preventing CA-AKI. Despite these limitations, for the first 
time, this study showed that hypochloremia may be independently associated with increased CA-AKI incidence 
especially in patients with normal kidney function, and that an increase in chloride level from the baseline level 
may be independently related to decrease of CA-AKI incidental rate in hypochloremic patients compared with a 
decrease in chloride level from the baseline, while in hyperchloremia, elevation of chloride rather increased the 
CA-AKI incidence.
In conclusion, hypochloremia might be significantly associated with increased CA-AKI especially in patients 
with normal kidney function and an increment of chloride might reduce the incidence of CA-AKI in hypochlo-
remic conditions. Hence, patients with hypochloremia and normal renal function at baseline should be mon-
itored closely when they need to undergo a contrast-CT examination. In the future, a randomized-controlled 
interventional study involving a larger population is needed to evaluate the association between increased chlo-
ride levels and the CA-AKI incident rate of hypochloremic patients.
Variables
Hypochloremia Hyperchloremia
RR (95% CI) P-value RR (95% CI) P-value
Normal Cr group (positive ΔCl 
vs. negative ΔCl) 0.318 (0.193–0.527)  < 0.001 3.092 (1.080–10.655) 0.036
Slightly increased Cr group 
(positive ΔCl vs. negative ΔCl) 0.053 (0.009–0.326) 0.002 — —
Table 4. Multivariate logistic regression analyses for the incidence of CA-AKI with delta chloride concentration 
within 72 hours in hypo- and hyperchloremia groups. Abbreviations; CA-AKI, contrast-associated acute 
kidney injury; RR, relative risk; CI, confidence interval; Cr, creatinine. ΔCl was defined by [post peak chloride 
concentration – chloride concentration at baseline]. Positive ΔCl was defined as ΔCl ≥ 0, while negative 
ΔCl was defined as ΔCl < 0. Adjusted for age, sex, BMI, admission status, comorbidity diseases (such as DM, 
hypertension, coronary artery disease, and heart failure), serum creatinine, serum BUN, tCO2, and contrast 
media volume. Normal Cr group; patients who had a serum Cr level of less than 1.2 mg/dL. Slightly increased Cr 
group; patients who had 1.2 ≤ serum Cr levels < 2.0 mg/dL. Hypochloremia; chloride level less than 98 mEq/L at 
baseline. Normochloremia; chloride level between 98 to 110 mEq/L at baseline. Hyperchloremia; chloride level 
over 110 mEq/L at baseline.
www.nature.com/scientificreports/
6SCIEnTIfIC REpORts | 7: 17431  | DOI:10.1038/s41598-017-17763-7
Materials and Methods
Study population. This retrospective and Health Insurance Portability and Accountability Act-compliant 
(HIPAA) study was approved by the institutional review board of Yonsei University College of Medicine and 
informed consent was waived. This study was performed in accordance with HIPAA. From January 2014 to 
December 2015, patients who met the following inclusion criteria were included in this study: 1) patients who 
underwent contrast-enhanced abdominal CT, 2) patients who had laboratory results including serum BUN, Cr 
and Cl levels within 1 month before CT examination and within 72 hours after CT examination. Through a search 
of the electronic medical database, 14,069 patients who met the inclusion criteria were found. Among them, 
patients who did not have laboratory results for the total CO2 level or the serum sodium level within 1 month 
before CT examination (n = 315) were excluded.
Additionally, 184 patients who were younger than 18 years old, and 482 patients who had more than 2.0 mg/
dL of serum Cr before CT examination were also excluded. Finally, 13,088 patients (mean age, 59.0 ± 15.3; male 
ratio, 58.3%) were included in this study (Fig. 3). Patients were divided into three groups according to the refer-
ence values of our institution: the hypochloremia group (serum Cl− < 98 mEq/L, n = 2,525), normochloremia 
group (98 ≤ serum Cl− ≤ 110 mEq/L, n = 10,322), and hyperchloremia group (serum Cl− > 110 mEq/L, n = 241).
Data collection. Data on baseline characteristics, including demographic information and preexisting 
chronic comorbidities were collected at the point of CT examination. Moreover, baseline laboratory data acquired 
within 1 month before CT examination were collected, and the peak values of post BUN and Cr concentrations 
were recorded within 72 hours after performing CT. In this study, we considered the last values obtained before 
the patient underwent CT as the baseline laboratory data, but we excluded patients who did not have laboratory 
results within 1 month before the CT procedure. We theorized that the last value obtained before CT examination 
would reflect each patient’s condition better than other laboratory values. Most of the inpatients in the current 
study had laboratory results obtained within 3 days before CT examination, and we assumed that these results 
would effectively show the status of each patient before CT procedure. Meanwhile, according to our hospital pol-
icy, laboratory results (especially BUN and Cr) obtained within 1 month before CT examination are considered 
as recent data for outpatients, while patients who do not have BUN/Cr results obtained within 1 month before 
CT procedure undergo laboratory tests. Hence, we set the ‘1 month before CT examination as the cut-off timeline 
for recent laboratory data. In addition, serum chloride concentrations were measured by indirect potentiometry 
(ADVIA 1800 Chemistry System; Siemens Healthcare Diagnostic Inc., Oakville, ON, Canada). We also measured 
chloride concentrations at the same time as serum post BUN and Cr concentrations to evaluate how changes in 
chloride levels affected the development of CA-AKI.
Definition. 
 1. CA-AKI was defined based on the KDIGO criteria with any of the following conditions; Increase in SCr 
by ≥0.3 mg/dL within 48 hours or increase in SCr to ≥1.5 times baseline, which is known or presumed to 
have occurred within the prior 7 days or urine volume < 0.5 mL/kg/h for 6 hours31.
 2. Post BUN was defined as the peak serum BUN concentration found within 72 hours after CT examination
 3. Post Cr was defined as the peak serum Cr concentration found within 72 hours after CT examination
 4. Delta creatinine level (ΔCr) (%) was defined by [Crwithin 72h − Crat baseline]/[Crat baseline] × 100(%).
•	 Crwithin 72h was defined by the peak value of serum Cr found within 72 hours after contrast administration.
•	 Crat baseline was defined as the serum Cr level found before contrast administration.
Figure 3. Flow chart of patients’ inclusion and subgrouping.
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 5. Delta chloride level (ΔCl) (mEq/L) was defined by [Cl−within 72h − Cl−at baseline].
•	 Cl−within 72h was defined by the peak value of chloride found within 72 hours after contrast administration.
•	 Cl−at baseline was defined as the chloride level found before contrast administration.
•	 Positive ΔCl was defined as ΔCl ≥ 0, while negative ΔCl was defined as ΔCl < 0.
Sub-analysis. All patients were separated into two groups with the normal reference range of serum Cr 
(1.2 mg/dL) used in our hospital; the ‘Normal Cr group’ had a serum Cr level of less than 1.2 mg/dL (n = 12,280) 
and the ‘Slightly increased Cr group’ had 1.2 ≤ serum Cr levels < 2.0 mg/dL (n = 808). We analyzed the associa-
tions between hypo- or hyperchloremia and the increase in CA-AKI occurrence for the ‘Normal Cr group’ and 
the ‘Slightly increased Cr group’, respectively. Moreover, all patients were also divided into two groups according 
to changes in chloride concentrations before and after CT examination: positive ΔCl and negative ΔCl. The effect 
of positive ΔCl on CA-AKI incidence was compared with the effect of negative ΔCl for the ‘Normal Cr group’ 
and the ‘Slightly increased Cr group’, respectively.
Statistical analysis. Statistical analysis was performed using SPSS for Windows, version 22.0 (SPSS Inc, 
Chicago, IL, USA). Continuous variables were presented as means ± standard deviations, and categorical varia-
bles were presented as numbers and percentages. Groups were compared with ANOVA for continuous variables 
and the χ2 test for categorical variables, respectively. Multivariate logistic regression analyses were conducted 
to estimate hypochloremia and hyperchloremia for the incidence of CA-AKI with relative risk (RR) and 95% 
confidence interval (CI). Among the significant covariates identified by univariate analysis (P < 0.1), several var-
iables were selected after correlation analysis to avoid multicollinearity (variance inflation factor < 10); age, sex, 
admission status of patients, the presence of DM, hypertension, CAD, heart failure, serum BUN, Cr, tCO2. A final 
multiple logistic regression analysis was then conducted in a backward stepwise manner. All tests were two-sided, 
and a P value of < 0.05 was considered statistically significant.
References
 1. Weisbord, S. D. & Palesvsky, P. M. Acute kidney injury: intravenous fluid to prevent contrast-induced AKI. Nat Rev Nephrol 5, 
256–257 (2009).
 2. Subramaniam, R. M. et al. Effectiveness of prevention strategies for contrast-induced nephropathy: A systematic review and meta-
analysis. Ann Intern Med 164, 406–416 (2016).
 3. Eng, J. et al. Comparative effect of contrast media type on the incidence of contrast-induced nephropathy: A systematic review and 
meta-analysis. Ann Intern Med 164, 417–424 (2016).
 4. Rihal, C. S. et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 
105, 2259–2264 (2002).
 5. Mueller, C. Prevention of contrast-induced nephropathy with volume supplementation. Kidney Int Suppl; https://doi.org/10.1038/
sj.ki.5000369. S16–19 (2006).
 6. Marenzi, G. et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 349, 1333–1340 
(2003).
 7. Marenzi, G. et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 354, 2773–2782 (2006).
 8. Merten, G. J. et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291, 
2328–2334 (2004).
 9. Stone, G. W. et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 
290, 2284–2291 (2003).
 10. Birck, R. et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362, 598–603 (2003).
 11. Hoffmann, U., Fischereder, M., Kruger, B., Drobnik, W. & Kramer, B. K. The value of N-acetylcysteine in the prevention of 
radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15, 407–410 (2004).
 12. Bader, B. D. et al. What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clin Nephrol 62, 1–7 
(2004).
 13. Trivedi, H. S. et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast 
nephrotoxicity. Nephron Clin Pract 93, C29–34 (2003).
 14. Soni, N. British Consensus Guidelines on Intravenous Fluid Therapy for Adult Surgical Patients (GIFTASUP): Cassandra’s view. 
Anaesthesia 64, 235–238 (2009).
 15. Myburgh, J. A. & Mythen, M. G. Resuscitation fluids. N Engl J Med 369, 1243–1251 (2013).
 16. O’Dell, E., Tibby, S. M., Durward, A. & Murdoch, I. A. Hyperchloremia is the dominant cause of metabolic acidosis in the 
postresuscitation phase of pediatric meningococcal sepsis. Crit Care Med 35, 2390–2394 (2007).
 17. Noritomi, D. T. et al. Metabolic acidosis in patients with severe sepsis and septic shock: a longitudinal quantitative study. Crit Care 
Med 37, 2733–2739 (2009).
 18. Moviat, M. et al. Stewart analysis of apparently normal acid-base state in the critically ill. J Crit Care 28, 1048–1054 (2013).
 19. Neyra, J. A. et al. Association of Hyperchloremia With Hospital Mortality in Critically Ill Septic Patients. Crit Care Med 43, 
1938–1944 (2015).
 20. Zhang, Z., Xu, X., Fan, H., Li, D. & Deng, H. Higher serum chloride concentrations are associated with acute kidney injury in 
unselected critically ill patients. BMC Nephrol 14, 235 (2013).
 21. Khanna, A. & Kurtzman, N. A. Metabolic alkalosis. J Nephrol 19(Suppl 9), S86–96 (2006).
 22. Kimura, S. et al. Association of serum chloride concentration with outcomes in postoperative critically ill patients: a retrospective 
observational study. J Intensive Care 2, 39 (2014).
 23. Tani, M., Morimatsu, H., Takatsu, F. & Morita, K. The incidence and prognostic value of hypochloremia in critically ill patients. 
ScientificWorldJournal 2012, 474185 (2012).
 24. Yunos, N. M. et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and 
kidney injury in critically ill adults. JAMA 308, 1566–1572 (2012).
 25. Valette, X. et al. Sodium Bicarbonate Versus Sodium Chloride for Preventing Contrast-Associated Acute Kidney Injury in Critically 
Ill Patients: A Randomized Controlled Trial. Crit Care Med, https://doi.org/10.1097/ccm.0000000000002267 (2017).
 26. Solomon, R. et al. Randomized Trial of Bicarbonate or Saline Study for the Prevention of Contrast-Induced Nephropathy in Patients 
with CKD. Clin J Am Soc Nephrol 10, 1519–1524 (2015).
www.nature.com/scientificreports/
8SCIEnTIfIC REpORts | 7: 17431  | DOI:10.1038/s41598-017-17763-7
 27. Angus, D. C. & van der Poll, T. Severe sepsis and septic shock. N Engl J Med 369, 840–851 (2013).
 28. Khanna, A. & Kurtzman, N. A. Metabolic alkalosis. J Nephrol 19, S86–S96 (2006).
 29. Terzano, C. et al. Mixed acid-base disorders, hydroelectrolyte imbalance and lactate production in hypercapnic respiratory failure: 
the role of noninvasive ventilation. PLoS One 7, e35245 (2012).
 30. Heyman, S. N., Rosen, S., Khamaisi, M., Idee, J. M. & Rosenberger, C. Reactive oxygen species and the pathogenesis of radiocontrast-
induced nephropathy. Invest Radiol 45, 188–195 (2010).
 31. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidndy Int Suppl 2, 1, https://doi.org/10.1038/kisup.2012.1 (2012).
Acknowledgements
This research was supported by Basic Science Research Program through the National Research Foundation of 
Korea (NRF) grant funded by the Korea government (MSIT) (2010–0027945 and NRF-2014R1A1A2057091).
Author Contributions
H.J.O. conceived the idea, prepared, analyzed data, performed statistical analysis, wrote the main manuscript 
text, and prepared figures and tables. He also contributed to critical correction of the paper. S.W.K. prepared and 
analyzed data. He also contributed to the writing and critical correction of the paper. J.T.P., He contributed to the 
writing and critical correction of the paper. S.J.K. He performed statistical analysis and contributed to the writing 
and critical correction of the paper. S.H.H. He contributed to the writing and critical correction of the paper. 
T.H.Y. He contributed to the writing and critical correction of the paper. D.R.R. He contributed to the writing and 
critical correction of the paper. S.W.K. He contributed to the writing and critical correction of the paper. Y.E.C. 
conceived the idea, prepared, analyzed data, performed statistical analysis, wrote the main manuscript text, and 
prepared figures and tables. He also contributed to the critical correction of the paper.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-017-17763-7.
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
